Results 121 to 130 of about 4,754 (217)

Miltefosine versus meglumine antimoniate in the treatment of mucosal leishmaniasis [PDF]

, 2014
El tratamiento convencional para la leishmaniasis tegumentaria es el antimoniato de meglumina, el cual presenta falla terapéutica creciente, producción de efectos adversos graves, y necesidad de administración parenteral, justificando la búsqueda de ...
Barrio, Alejandra, Basombrio, Miguel Angel Manuel, Beckar, Josefina, Garcia Bustos, Maria Fernanda, Moreno, Sonia, Parodi Ramoneda, Cecilia María   +5 more
core  

Correction: Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial. [PDF]

PLoS Negl Trop Dis, 2023
Lago J, Fraga D, Guimarães LH, Lago T, Silva YJ, Lago E, Werneck GL, Bacellar O, Carvalho EM.   +8 more
europepmc   +1 more source

Hepatitis with Fibrin-Ring Granulomas [PDF]

, 2018
: We describe a 66-year-old woman hospitalized with fever, fatigue and hepatopathy. In her medical history arterial hypertension (treated with propranolol and lisinopril), diabetes mellitus type 2 (no treatment before admission) and a gout arthropathy ...
Bodmer, M., Fluckiger, U., Heim, M., Khanlari, B., Terracciano, L., Weisser, M.   +5 more
core  

Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial. [PDF]

PLoS Negl Trop Dis, 2023
Lago J, Fraga D, Guimarães LH, Lago T, Silva YJ, Lago E, Werneck GL, Bacellar O, Carvalho EM.   +8 more
europepmc   +1 more source

Tremor and generalized mioclonus caused by meglumine antimoniate

, 2020
Cutaneous Leishmaniasis is an endemic pathology in Peru, the first line treatment being pentavalent antimonials. Occasional antimonials as the side effect, neurological symptoms that can become incapacitating, so we must be strict in the dosage at the time of administration.
Torres-Ramírez, Luis, Pérez-Almedo, Melissa, Vélez-Rojas, Miriam, Flores-Mendoza, Martha, Arias-Hancco, Víctor   +4 more
openaire   +1 more source

Intralesional Meglumine Antimoniate: Safe, Feasible and Effective Therapy for Cutaneous Leishmaniasis in Bolivia. [PDF]

Trop Med Infect Dis, 2022
Rojas Cabrera E, Verduguez-Orellana A, Tordoya-Titichoca IJ, Sejas C, Ledezma R, Álvarez I, Limachi-Choque J, Ortuño-Gutiérrez N, Córdova Rojas M, Guzman-Rivero M.   +9 more
europepmc   +1 more source

Leishmaniosis: estado actual y perspectivas de futuro [PDF]

, 2010
Discurso de Ingreso en la Real Academia de Ciencias Veterinarias de Andalucía Oriental como Académico ...
Sillero F. de Cañete, J.
core  

Disseminated cutaneous leishmaniasis caused by Leishmania braziliensis in Southern Brazil

Revista do Instituto de Medicina Tropical de São Paulo
The authors report a case of disseminated cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis, in a 55 years old patient with 1,119 lesions distributed throughout the body.
Norberto Assis Membrive, Flávio Jun Kazuma, Thaís Gomes Verzignassi Silveira, Jorge Juarez Vieira Teixeira, Kárin Rosi Reinhold-Castro, Ueslei Teodoro   +5 more
doaj   +1 more source

Is There Any Difference in the In Situ Immune Response in Active Localized Cutaneous Leishmaniasis That Respond Well or Poorly to Meglumine Antimoniate Treatment or Spontaneously Heal? [PDF]

Microorganisms, 2023
Leite-Silva J, Oliveira-Ribeiro C, Morgado FN, Pimentel MIF, Lyra MR, Fagundes A, Miranda LFC, Valete-Rosalino CM, Schubach AO, Conceição-Silva F.   +9 more
europepmc   +1 more source

Molecular-based detection of Leishmania tropica isolates among sensitive, resistant, and relapsed patients treated with Meglumine Antimoniate. [PDF]

J Parasit Dis, 2022
Vazin A, Heidaripour MS, Kalantari M, Hatam G.   +3 more
europepmc   +1 more source